Israeli Researchers Develop Joint Treatment for Alzheimer’s, Autism
Israeli researchers have developed a joint treatment for autistic and Alzheimer’s patients, Tel Aviv University (TAU) said Tuesday.
In a study led by TAU researchers and published in the journal Molecular Psychiatry, the team discovered a high overlap in Alzheimer’s genes undergoing mutations with genes that impact autism and intellectual disability.
View Full ArticleYou need to login or register to bookmark/favorite this content.